To achieve this, we have performed comprehensive plasma amino acid analysis post-asparaginase administration in both AML and PDAC-bearing mouse models and in a clinical trial of patients with R/R AML treated with Erwinaze. This evidence concerns the gene ASPG and acute myeloid leukemia.